Streetbeat News

Analyst Ratings

ORIC

Wedbush analyst David Nierengarten has reiterated his 'Outperform' rating on ORIC Pharmaceuticals (NASDAQ:ORIC), maintaining a price target of $14.

Portfolio Pulse from Benzinga Newsdesk

October 23, 2023 | 1:09 pm

VCYT

Goldman Sachs analyst Matthew Sykes has maintained a 'Buy' rating on Veracyte (NASDAQ:VCYT) but lowered the price target from $37 to $32.

Portfolio Pulse from Benzinga Newsdesk

October 23, 2023 | 1:07 pm

SEDG

Goldman Sachs analyst Brian Lee has maintained a Neutral rating on SolarEdge Technologies (NASDAQ:SEDG) and lowered the price target from $254 to $131.

Portfolio Pulse from Benzinga Newsdesk

October 23, 2023 | 1:05 pm

RF

Goldman Sachs analyst Ryan Nash maintains a Buy rating on Regions Financial (NYSE:RF) but lowers the price target from $22.5 to $19.5.

Portfolio Pulse from Benzinga Newsdesk

October 23, 2023 | 1:02 pm

ACU

Acme United (AMEX:ACU) reported Q3 earnings of $0.58 per share, missing the analyst consensus estimate of $0.70 by 17.14%. The company's quarterly sales were $50.40 million, missing the estimate of $51.24 million by 1.64%. However, both earnings and sales increased compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

October 23, 2023 | 1:00 pm

COTY

In the last quarter, Coty (NYSE:COTY) received 2 somewhat bullish and 10 indifferent analyst ratings. The company's average 12-month price target is $12.19, a decrease of 6.01% from the previous average of $12.97. Analysts arrive at their conclusions by predicting a company's future earnings and the predictability of its revenue streams.

Portfolio Pulse from Benzinga Insights

October 23, 2023 | 1:00 pm

HBAN

Over the past 3 months, 3 analysts have published their opinion on Huntington Bancshares (NASDAQ:HBAN) stock. The analysts have an average price target of $12.0 versus the current price of Huntington Bancshares at $9.65. This current average has decreased by 5.88% from the previous average price target of $12.75.

Portfolio Pulse from Benzinga Insights

October 23, 2023 | 1:00 pm

MOS

Analysts have provided mixed ratings for Mosaic (NYSE:MOS) in the last quarter, with 2 bullish, 6 indifferent, and 2 somewhat bearish. The average 12-month price target is $41.4, representing a 0.74% decrease from the previous average price target of $41.71.

Portfolio Pulse from Benzinga Insights

October 23, 2023 | 1:00 pm

IONS

In the last quarter, Ionis Pharmaceuticals (NASDAQ:IONS) received 7 analyst ratings, with 4 being bullish, 1 somewhat bullish, and 2 indifferent. Over the past 3 months, 7 analysts have offered 12-month price targets for Ionis Pharmaceuticals, with an average price target of $57.86, a high of $65.00, and a low of $45.00. The average price target has increased by 56.38% over the past month.

Portfolio Pulse from Benzinga Insights

October 23, 2023 | 1:00 pm

BKNG

Analysts have provided various ratings for Booking Holdings (NASDAQ:BKNG) within the last quarter, with a majority leaning towards bullish. The average 12-month price target for Booking Holdings has increased by 13.14% from the previous average price target of $3127.70 to $3538.82.

Portfolio Pulse from Benzinga Insights

October 23, 2023 | 1:00 pm